Aquestive Therapeutics (AQST) Interest Coverage Ratio (2017 - 2025)
Historic Interest Coverage Ratio for Aquestive Therapeutics (AQST) over the last 9 years, with Q3 2025 value amounting to 4.13.
- Aquestive Therapeutics' Interest Coverage Ratio fell 3851.79% to 4.13 in Q3 2025 from the same period last year, while for Sep 2025 it was 5.02, marking a year-over-year decrease of 15236.96%. This contributed to the annual value of 2.77 for FY2024, which is 1609.35% down from last year.
- As of Q3 2025, Aquestive Therapeutics' Interest Coverage Ratio stood at 4.13, which was down 3851.79% from 4.09 recorded in Q2 2025.
- In the past 5 years, Aquestive Therapeutics' Interest Coverage Ratio ranged from a high of 0.02 in Q2 2024 and a low of 7.81 during Q2 2022
- Over the past 5 years, Aquestive Therapeutics' median Interest Coverage Ratio value was 3.22 (recorded in 2024), while the average stood at 4.04.
- Per our database at Business Quant, Aquestive Therapeutics' Interest Coverage Ratio skyrocketed by 10064.56% in 2024 and then crashed by 2075422.64% in 2025.
- Over the past 5 years, Aquestive Therapeutics' Interest Coverage Ratio (Quarter) stood at 6.69 in 2021, then increased by 2.96% to 6.49 in 2022, then surged by 73.5% to 1.72 in 2023, then crashed by 183.98% to 4.89 in 2024, then increased by 15.47% to 4.13 in 2025.
- Its last three reported values are 4.13 in Q3 2025, 4.09 for Q2 2025, and 6.96 during Q1 2025.